Cargando…

US Hospital Characteristics Associated With Price Transparency Regulation Compliance

This cross-sectional study examines associations between characteristics of US hospitals and their compliance with Centers for Medicare & Medicaid Services regulations for transparency of insurance-negotiated prices.

Detalles Bibliográficos
Autores principales:	Ji, Yunan, Kong, Edward
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233236/ https://www.ncbi.nlm.nih.gov/pubmed/35977242 http://dx.doi.org/10.1001/jamahealthforum.2022.1702

Ejemplares similares

Provision of Hospital Price Information After Increases in Financial Penalties for Failure to Comply With a US Federal Hospital Price Transparency Rule
por: Kong, Edward, et al.
Publicado: (2023)

Transparency, Accessibility, and Variability of US Hospital Price Data
por: Haque, Waqas, et al.
Publicado: (2021)

Hospital noncompliance with U.S. price transparency regulations
por: Miller, Amitai S., et al.
Publicado: (2022)

Transparency and Variability in Pricing for Pediatric Outpatient Imaging in US Children’s Hospitals
por: Hayatghaibi, Shireen E., et al.
Publicado: (2022)

Mohs Surgery Price Transparency and Variability at Academic Hospitals After the Implementation of the Federal Price Transparency Final Rule
por: Jain, Neelesh P, et al.
Publicado: (2023)

Factors Associated with Compliance to the Hospital Price Transparency Final Rule: a National Landscape Study
por: Jiang, John Xuefeng, et al.
Publicado: (2021)

PC5. Compliance with Price Transparency for Carpal Tunnel Surgery
por: Moon, Tina, et al.
Publicado: (2023)

Price Transparency for COVID-19 Testing Among Top US Hospitals
por: Xiao, Roy, et al.
Publicado: (2020)

Comparison of US Hospital Cash Prices and Commercial Negotiated Prices for 70 Services
por: Jiang, John (Xuefeng), et al.
Publicado: (2021)

Analysis of State-Level Drug Pricing Transparency Laws in the United States
por: Ryan, Martha S., et al.
Publicado: (2019)

Transparency in Coverage Data and Variation in Prices for Common Health Care Services
por: Chartock, Benjamin L., et al.
Publicado: (2023)

Evaluation of Prices for Surgical Procedures Within and Outside Hospital Networks in the US
por: Mullens, Cody Lendon, et al.
Publicado: (2023)

Enhancing medicine price transparency through price information mechanisms
por: Hinsch, Michael, et al.
Publicado: (2014)

Correlates of Price Transparency for Healthcare Services in United States Hospitals
por: Younessi, David N, et al.
Publicado: (2022)

Are payors ready for transparent prices yet?
por: Barman-Aksözen, Jasmin
Publicado: (2022)

Assessment of Public Opinion on Transparency at the US Food and Drug Administration
por: Azad, Tej D., et al.
Publicado: (2022)

Use Patterns of a State Health Care Price Transparency Web Site: What Do Patients Shop For?
por: Mehrotra, Ateev, et al.
Publicado: (2014)

Variance of US Hospital Characteristics by Safety-Net Definition
por: McNeill, Elizabeth, et al.
Publicado: (2023)

Healthcare price transparency in North America and Europe
por: Araich, Harman, et al.
Publicado: (2023)

Estimating the Impact of New Health Price Transparency Policies
por: Parente, Stephen T.
Publicado: (2023)

Trends in Annual Sales and Pack Price of Cigarettes in the US, 2015-2021
por: Ali, Fatma Romeh M., et al.
Publicado: (2022)

Hospital Prices in Medicaid Managed Care
por: Marr, Jeffrey, et al.
Publicado: (2023)

Assessment of US Pharmacies Contracted With Health Care Institutions Under the 340B Drug Pricing Program by Neighborhood Socioeconomic Characteristics
por: Lin, John K., et al.
Publicado: (2022)

Comparison of Commercial Negotiated Price and Cash Price Between Physician-Owned Hospitals and Other Hospitals in the Same Hospital Referral Region
por: Wang, Yang, et al.
Publicado: (2023)

The impact of price transparency and competition on hospital costs: a research on all-payer claims databases
por: Han, Ahreum, et al.
Publicado: (2022)

Association Between US Drug Price and Measures of Efficacy for Oncology Drugs Approved by the US Food and Drug Administration From 2015 to 2020
por: Miljković, Miloš D., et al.
Publicado: (2022)

Assessment of US Hospital Compliance With Regulations for Patients’ Requests for Medical Records
por: Lye, Carolyn T., et al.
Publicado: (2018)

The impact of hospital price and quality transparency tools on healthcare spending: a systematic review
por: Chen, Jinyang, et al.
Publicado: (2022)

Just Because (Most) Hospitals Are Publishing Charges Does Not Mean Prices Are More Transparent
por: Mullens, Cody Lendon, et al.
Publicado: (2020)

Pricing and reimbursement of orphan drugs: the need for more transparency
por: Simoens, Steven
Publicado: (2011)

Is there transparency in the pricing of medicines in the South African private sector?
por: Bangalee, V, et al.
Publicado: (2018)

Affordable Prices Without Threatening the Oncological R&D Pipeline—An Economic Experiment on Transparency in Price Negotiations
por: Franzen, Nora, et al.
Publicado: (2022)

Variability in Prices Paid for Hemodialysis by Employer-Sponsored Insurance in the US From 2012 to 2019
por: League, Riley J., et al.
Publicado: (2022)

Factors Associated With Hospital Commercial Negotiated Price for Magnetic Resonance Imaging of Brain
por: Jiang, John Xuefeng, et al.
Publicado: (2023)

Commercial COVID-19 PCR Test Price in US Hospitals
por: Jiang, John Xuefeng, et al.
Publicado: (2023)

Strong Public Desire for Quality and Price Transparency in Shoulder Arthroplasty
por: Menendez, Mariano E, et al.
Publicado: (2022)

Does price disclosure in pharmaceutical advertising result in price transparency? Evidence from a randomized experiment
por: Hollin, Ilene L., et al.
Publicado: (2022)

Characteristics of and Mortality Associated With Diabetic Ketoacidosis Among US Patients Hospitalized With or Without COVID-19
por: Pasquel, Francisco J., et al.
Publicado: (2021)

Who Uses a Price Transparency Tool? Implications for Increasing Consumer Engagement
por: Gourevitch, Rebecca A., et al.
Publicado: (2017)

Transparent by choice: Proactive disclosures increase compliance with digital defaults
por: Paunov, Yavor, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7s3dlq6nj3rhg8ja4gavug2uvq